| Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study S Stringhini, A Wisniak, G Piumatti, AS Azman, SA Lauer, H Baysson, ... The Lancet 396 (10247), 313-319, 2020 | 1110 | 2020 |
| Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy GM Clifford, J Polesel, M Rickenbach, L Dal Maso, O Keiser, A Kofler, ... Journal of the National Cancer Institute 97 (6), 425-432, 2005 | 1041 | 2005 |
| Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies LF Johnson, J Mossong, RE Dorrington, M Schomaker, CJ Hoffmann, ... PLoS medicine 10 (4), e1001418, 2013 | 504 | 2013 |
| Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients M Rotger, S Colombo, H Furrer, G Bleiber, T Buclin, BL Lee, O Keiser, ... Pharmacogenetics and genomics 15 (1), 1-5, 2005 | 477 | 2005 |
| Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries MWG Brinkhof, F Dabis, L Myer, DR Bangsberg, A Boulle, D Nash, ... Bulletin of the World Health Organization 86 (7), 559-567, 2008 | 430 | 2008 |
| Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi L Tenthani, AD Haas, H Tweya, A Jahn, JJ Van Oosterhout, ... Aids 28 (4), 589-598, 2014 | 415 | 2014 |
| Changing patterns of cancer incidence in the early-and late-HAART periods: the Swiss HIV Cohort Study S Franceschi, M Lise, GM Clifford, M Rickenbach, F Levi, M Maspoli, ... British journal of cancer 103 (3), 416-422, 2010 | 323 | 2010 |
| Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub‐Saharan Africa: systematic review and meta‐analysis C Mugglin, J Estill, G Wandeler, N Bender, M Egger, T Gsponer, O Keiser, ... Tropical Medicine & International Health 17 (12), 1509-1520, 2012 | 292 | 2012 |
| Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes M May, A Boulle, S Phiri, E Messou, L Myer, R Wood, O Keiser, ... The Lancet 376 (9739), 449-457, 2010 | 265 | 2010 |
| Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland J Perez-Saez, SA Lauer, L Kaiser, S Regard, E Delaporte, I Guessous, ... The Lancet Infectious Diseases 21 (4), e69-e70, 2021 | 232 | 2021 |
| Long-term immunologic response to antiretroviral therapy in low-income countries: Collaborative analysis of prospective studies: The Antiretroviral Therapy in Lower Income … D Nash, M Katyal, MWG Brinkhof, O Keiser, M May, R Hughes, F Dabis, ... AIDS (London, England) 22 (17), 2291, 2008 | 230 | 2008 |
| Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients A Muzzi, G Leandro, L Rubbia-Brandt, R James, O Keiser, R Malinverni, ... Journal of hepatology 42 (1), 41-46, 2005 | 227 | 2005 |
| Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings M Forster, C Bailey, MWG Brinkhof, C Graber, A Boulle, M Spohr, ... Bulletin of the World Health Organization 86, 939-947, 2008 | 219 | 2008 |
| Missed opportunities to prevent mother-to-child-transmission: systematic review and meta-analysis C Wettstein, C Mugglin, M Egger, N Blaser, LS Vizcaya, J Estill, N Bender, ... Aids 26 (18), 2361-2373, 2012 | 211 | 2012 |
| Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents M Rothenbühler, CJ O'Sullivan, S Stortecky, GG Stefanini, E Spitzer, ... The Lancet Global Health 2 (12), e717-e726, 2014 | 191 | 2014 |
| Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study AD Haas, L Tenthani, MT Msukwa, K Tal, A Jahn, OJ Gadabu, A Spoerri, ... The lancet HIV 3 (4), e175-e182, 2016 | 188 | 2016 |
| Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring O Keiser, H Tweya, A Boulle, P Braitstein, M Schechter, MWG Brinkhof, ... AIDS (London, England) 23 (14), 1867, 2009 | 179 | 2009 |
| Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa MP Fox, G Van Cutsem, J Giddy, M Maskew, O Keiser, H Prozesky, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 60 (4), 428-437, 2012 | 178 | 2012 |
| Adherence to antiretroviral therapy during and after pregnancy: cohort study on women receiving care in Malawi's option B+ program AD Haas, MT Msukwa, M Egger, L Tenthani, H Tweya, A Jahn, ... Clinical infectious diseases 63 (9), 1227-1235, 2016 | 171 | 2016 |
| Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared O Keiser, C Orrell, M Egger, R Wood, MWG Brinkhof, H Furrer, ... PLoS medicine 5 (7), e148, 2008 | 166 | 2008 |
